Why Lucira Health Shares Are Trading Higher By Over 228%; Here Are 20 Stocks Moving Premarket



  • Lucira Health, Inc. LHDX rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses.
  • ObsEva SA OBSV rose 60.3% to $0.1331 in pre-market trading. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland.
  • Monopar Therapeutics Inc. MNPR rose 19.8% to $3.92 in pre-market trading.
  • Troika Media Group, Inc. TRKA rose 16.4% to $0.3550 in pre-market trading after gaining over 17% on Friday.
  • Inpixon INPX rose 13% to $1.30 in pre-market trading.
  • Seagen Inc. SGEN rose 12.8% to $182.00 in pre-market trading. Pfizer is in early discussions to purchase Seagen in a deal likely valued at more than $30 billion, The Wall Street Journal reported late on Sunday.
  • Kiromic BioPharma, Inc. KRBP shares rose 12.4% to $0.1910 in pre-market trading after gaining over 5% on Friday.
  • AERWINS Technologies Inc. AWIN shares rose 10.7% to $1.86 in pre-market trading after gaining more than 10% on Friday.
  • Molekule Group, Inc. MKUL rose 9% to $2.67 in pre-market trading after the company agreed to acquire Aura Smart Air Ltd, in an all-stock merger with a value of around $10 million.
  • Bed Bath & Beyond Inc. BBBY shares rose 7.8% to $1.65 in pre-market trading.


  • TEGNA Inc. TGNA shares fell 24% to $16.61 in pre-market trading after the Federal Communications Commission announced plans to hold a hearing on Standard General's bid for Tegna.
  • Cyren Ltd. CYRN fell 19.1% to $0.2750 in pre-market trading after surging around 62% on Friday. CYREN, last week, said it will be delisted from the Nasdaq.
  • Connexa Sports Technologies Inc. CNXA fell 14% to $0.18 in pre-market after jumping more than 49% on Friday.
  • Ocean Biomedical, Inc. OCEA shares dropped 13.9% to $8.60 in pre-market trading after dropping over 7% on Friday. Ocean Biomedical recently issued a press release celebrating the discovery of bispecific antibodies and immune checkpoint inibitors that kill glioblastoma cells and melanoma cells and block the metastasis of malignant melanoma cells to the lung by over 90%.
  • Jounce Therapeutics, Inc. JNCE fell 7% to $1.07 in pre-market trading after gaining around 5% on Friday. Jounce Therapeutics and Redx recently announced a recommended business combination.
  • Taboola.com Ltd. TBLA fell 7% to $3.07 in pre-market trading. Taboola.com shares dropped 19% on Friday after the company reported Q4 financial results.
  • SeqLL Inc. SQL fell 6.5% to $0.71 in pre-market trading. SeqLL recently announced pricing of an $1.8 million registered direct offering.
  • Zenvia Inc. ZENV fell 6% to $1.10 in pre-market trading. Zenvia recently launched the integration of its mass texting service solution, Zenvia Attraction, with ChatGPT (GPT-3) via API.
  • Protalix BioTherapeutics, Inc. PLX shares fell 5% to $1.73 in pre-market trading after gaining 7% on Friday. Chiesi Global Rare Diseases and Protalix BioTherapeutics recently received CHMP opinion for pegunigalsidase alfa for treatment of Fabry disease.
  • Kosmos Energy Ltd. KOS fell 5% to $7.18 in pre-market trading after posting results for its fourth quarter. The company said it sees Q1 capex of $200 million to $225 million.

Now Read This: Investor Optimism Declines Following Inflation Report

Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapPre-Market OutlookMarketsMoversTrading IdeasPremarket MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!